Literature DB >> 8992198

Cerebrovascular changes in rats during ischemia and reperfusion: a comparison of BOLD and first pass bolus tracking techniques.

R A Jones1, T B Müller, O Haraldseth, A M Baptista, A N Oksendal.   

Abstract

Both first pass bolus tracking of a susceptibility contrast agent and blood oxygenation level dependent (BOLD) sequences provide information on the tissue perfusion and the cerebral blood volume, but each sequence has its own particular limitations. In this article, both techniques were used to assess the cerebrovascular changes occurring in a rat model of focal cerebral ischemia with reperfusion after 2 h of ischemia. The blood oxygenation level dependent studies were performed before, during, and after 60 s of anoxia to observe the response of the tissue to a respiratory challenge. Both techniques were able to detect ischemia and reperfusion; however, first pass bolus tracking provided better sensitivity and was easier to interpret. Because the blood oxygenation level dependent sequence did not provide any additional information, bolus tracking would appear to be the method of choice for studies of cerebral ischemia with reperfusion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8992198     DOI: 10.1002/mrm.1910350407

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  2 in total

1.  Detection of light images by simple tissues as visualized by photosensitized magnetic resonance imaging.

Authors:  Catherine Tempel-Brami; Iddo Pinkas; Avigdor Scherz; Yoram Salomon
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

2.  Calcium channel blockade with nimodipine reverses MRI evidence of cerebral oedema following acute hypoxia.

Authors:  Matthew J Rowland; Martyn Ezra; Anderson Winkler; Payashi Garry; Catherine Lamb; Michael Kelly; Thomas W Okell; Jon Westbrook; Richard G Wise; Gwenaëlle Douaud; Kyle Ts Pattinson
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-31       Impact factor: 6.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.